Elan Ezickson
Director/Board Member en MARINUS PHARMACEUTICALS, INC. .
Fortuna: 50 624 $ al 31/03/2024
Perfil
Elan Z.
Ezickson currently works at Marinus Pharmaceuticals, Inc., as Independent Director from 2019, The Greater Boston Food Bank, as Director, Carmine Therapeutics Pte Ltd., as Director, Asylia Therapeutics, Inc., as Co-President & Director, Nirogy Therapeutics, Inc., as Director, and Carmine Therapeutics, Inc., as Director from 2019.
Mr. Ezickson also formerly worked at Sporos Bioventures, Inc., as Chief Executive Officer & Director from 2020 to 2021, Alaunos Therapeutics, Inc., as Independent Director from 2018 to 2020, Tvardi Therapeutics, Inc., as Director, Biogen MA, Inc., as Associate General Counsel in 1996, Biogen, Inc., as President-Biogen Canada from 1994 to 2003, Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC, as Attorney, AVEO Pharmaceuticals, Inc., as Chief Operating Officer & Executive Vice President from 2012 to 2013, Biogen Canada, Inc., as President from 1994 to 2003, and Scholar Rock Holding Corp., as COO & Head-Corporate Development from 2017 to 2018.
Mr. Ezickson received his undergraduate degree in 1984 from Yale University and graduate degree in 1988 from Columbia Law School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/04/2024 | 5 600 ( 0.01% ) | 50 624 $ | 31/03/2024 |
Cargos activos de Elan Ezickson
| Empresas | Cargo | Inicio |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Director/Board Member | 12/12/2019 |
Carmine Therapeutics Pte Ltd.
 Carmine Therapeutics Pte Ltd. Pharmaceuticals: MajorHealth Technology Carmine Therapeutics Pte Ltd. develops and manufactures medicines based on red blood cell extracellular vesicles. The company was founded by Harvey Lodish, Minh Le, XiangQian Lin and Jiahai Shi in 2019 and is headquartered in Singapore. | Director/Board Member | - |
Nirogy Therapeutics, Inc.
 Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Nirogy Therapeutics, Inc. is an American biotechnology company that operates in the healthcare industry. The company is based in N/A. The company was founded in 2014 by Vincent Sandanayaka, Jaime Escobedo. Simon C. Pedder has been the CEO of the company since 2022. | Director/Board Member | - |
Asylia Therapeutics, Inc.
 Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | President | - |
The Greater Boston Food Bank
 The Greater Boston Food Bank Miscellaneous Commercial ServicesCommercial Services The Greater Boston Food Bank is the largest hunger-relief organization in the country, providing nearly 90 million meals per year to people in 190 towns across the region. The Greater Boston Food Bank is based in Boston, MA. The organization is committed to ending hunger and believes that access to healthy food is a human right. The non-profit company works towards this goal through policy, partnerships, and providing free, nutritious, and culturally responsive food. Catherine D'Amato has been the CEO of the company since 1995. | Director/Board Member | 21/12/2009 |
| Carmine Therapeutics, Inc. | Director/Board Member | 01/01/2019 |
Antiguos cargos conocidos de Elan Ezickson.
| Empresas | Cargo | Fin |
|---|---|---|
Tvardi Therapeutics, Inc.
 Tvardi Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tvardi Therapeutics, Inc. develops and commercializes medicines for the treatment of diverse cancers, chronic inflammatory and fibrotic diseases. The company was founded by David J. Tweardy and Ronald A. DePinho in 2017 and is headquartered in Houston, TX. | Director/Board Member | 11/03/2021 |
Sporos Bioventures, Inc.
 Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Chief Executive Officer | 01/03/2021 |
| ALAUNOS THERAPEUTICS, INC. | Director/Board Member | 04/12/2020 |
| ░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formación de Elan Ezickson.
| Yale University | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Empresas privadas | 11 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Commercial Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
| Biogen Canada, Inc. | |
Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tvardi Therapeutics, Inc. develops and commercializes medicines for the treatment of diverse cancers, chronic inflammatory and fibrotic diseases. The company was founded by David J. Tweardy and Ronald A. DePinho in 2017 and is headquartered in Houston, TX. | Commercial Services |
Carmine Therapeutics Pte Ltd.
Carmine Therapeutics Pte Ltd. Pharmaceuticals: MajorHealth Technology Carmine Therapeutics Pte Ltd. develops and manufactures medicines based on red blood cell extracellular vesicles. The company was founded by Harvey Lodish, Minh Le, XiangQian Lin and Jiahai Shi in 2019 and is headquartered in Singapore. | Health Technology |
Asylia Therapeutics, Inc.
Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | Health Technology |
Nirogy Therapeutics, Inc.
Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Nirogy Therapeutics, Inc. is an American biotechnology company that operates in the healthcare industry. The company is based in N/A. The company was founded in 2014 by Vincent Sandanayaka, Jaime Escobedo. Simon C. Pedder has been the CEO of the company since 2022. | Health Technology |
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Health Services |
| Carmine Therapeutics, Inc. | |
The Greater Boston Food Bank
The Greater Boston Food Bank Miscellaneous Commercial ServicesCommercial Services The Greater Boston Food Bank is the largest hunger-relief organization in the country, providing nearly 90 million meals per year to people in 190 towns across the region. The Greater Boston Food Bank is based in Boston, MA. The organization is committed to ending hunger and believes that access to healthy food is a human right. The non-profit company works towards this goal through policy, partnerships, and providing free, nutritious, and culturally responsive food. Catherine D'Amato has been the CEO of the company since 1995. | Commercial Services |
- Bolsa de valores
- Insiders
- Elan Ezickson
